Caxton Associates (New York)’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-66,393
Closed -$928K 562
2022
Q3
$928K Sell
66,393
-6,802
-9% -$137K 0.12% 133
2022
Q2
$1.76M Buy
73,195
+50,304
+220% +$1.35M 0.17% 45
2022
Q1
$706K Buy
22,891
+16,518
+259% +$594K 0.06% 167
2021
Q4
$289K Hold
6,373
0.03% 423
2021
Q3
$277K Buy
+6,373
New +$277K 0.03% 334

Other funds holding NEOG

Caxton Associates (New York)'s NEOG Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Neogen (NEOG) in Q4 2022, closing a stake of 66,393 shares — an estimated $928K sold.

Caxton Associates (New York) first reported a position in NEOG in Q3 2021 and held it in 5 quarters. The position peaked at $1.76M in Q2 2022. 370 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 66,393 Neogen shares in Q4 2022, an estimated $928K.
  • Caxton Associates (New York) first reported a position in Neogen in Q3 2021 and held it in 5 quarters.
  • Caxton Associates (New York)'s Neogen position peaked at $1.76M in Q2 2022.
  • 370 funds tracked by Wall St. Rank held Neogen as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.